BACKGROUND: Transforming growth factors betas (TGF-betas) are implicated in pancreatic tissue repair but their role in acute pancreatitis is not known. To determine whether endogenous TGF-betas modulate the course of caerulein induced acute pancreatitis, caerulein was administered to wild-type (FVB-/-) and transgenic mice that are heterozygous (FVB+/-) for expression of a dominant negative type II TGF-beta receptor. METHODS: After 7 hourly supramaximal injections of caerulein, the pancreas was evaluated histologically and serum was assayed for amylase and lipase levels. Next, the effects of caerulein on amylase secretion were determined in mouse pancreatic acini, and cholecystokinin (CCK) receptor expression was assessed. RESULTS: The normal mouse pancreas was devoid of inflammatory cells whereas the pancreas from transgenic mice contained lymphocytic infiltrates. Caerulein injection in wild-type mice resulted in 6- and 36-fold increases in serum amylase and lipase levels, respectively, increased serum trypsinogen activation peptide (TAP) levels, gross oedema and a marked inflammatory response in the pancreas that consisted mainly of neutrophils and macrophages. By contrast, FVB+/- mice exhibited minimal alterations in response to caerulein with attenuated neutrophil-macrophage infiltrates. Moreover, acini from FVB+/- mice did not exhibit restricted stimulation at high caerulein concentrations, even though CCK receptor mRNA levels were not decreased. CONCLUSION: Our findings indicate that a functional TGF-beta signalling pathway may be required for caerulein to induce acute pancreatitis and for the CCK receptor to induce acinar cell damage at high ligand concentrations. Our results also support the concept that restricted stimulation at high caerulein concentrations contributes to the ability of caerulein to induce acute pancreatitis.
BACKGROUND: Transforming growth factors betas (TGF-betas) are implicated in pancreatic tissue repair but their role in acute pancreatitis is not known. To determine whether endogenous TGF-betas modulate the course of caerulein induced acute pancreatitis, caerulein was administered to wild-type (FVB-/-) and transgenic mice that are heterozygous (FVB+/-) for expression of a dominant negative type II TGF-beta receptor. METHODS: After 7 hourly supramaximal injections of caerulein, the pancreas was evaluated histologically and serum was assayed for amylase and lipase levels. Next, the effects of caerulein on amylase secretion were determined in mousepancreatic acini, and cholecystokinin (CCK) receptor expression was assessed. RESULTS: The normal mouse pancreas was devoid of inflammatory cells whereas the pancreas from transgenic mice contained lymphocytic infiltrates. Caerulein injection in wild-type mice resulted in 6- and 36-fold increases in serum amylase and lipase levels, respectively, increased serum trypsinogen activation peptide (TAP) levels, gross oedema and a marked inflammatory response in the pancreas that consisted mainly of neutrophils and macrophages. By contrast, FVB+/- mice exhibited minimal alterations in response to caerulein with attenuated neutrophil-macrophage infiltrates. Moreover, acini from FVB+/- mice did not exhibit restricted stimulation at high caerulein concentrations, even though CCK receptor mRNA levels were not decreased. CONCLUSION: Our findings indicate that a functional TGF-beta signalling pathway may be required for caerulein to induce acute pancreatitis and for the CCK receptor to induce acinar cell damage at high ligand concentrations. Our results also support the concept that restricted stimulation at high caerulein concentrations contributes to the ability of caerulein to induce acute pancreatitis.
Authors: Walter Halangk; Burkhard Krüger; Manuel Ruthenbürger; Jörg Stürzebecher; Elke Albrecht; Hans Lippert; Markus M Lerch Journal: Am J Physiol Gastrointest Liver Physiol Date: 2002-02 Impact factor: 4.052
Authors: E P Böttinger; J L Jakubczak; I S Roberts; M Mumy; P Hemmati; K Bagnall; G Merlino; L M Wakefield Journal: EMBO J Date: 1997-05-15 Impact factor: 11.598
Authors: Y Kikuchi; T Shimosegawa; S Moriizumi; K Kimura; A Satoh; M Koizumi; I Kato; C J Epstein; T Toyota Journal: Biochem Biophys Res Commun Date: 1997-04-07 Impact factor: 3.575
Authors: P C Konturek; A Dembiński; Z Warzecha; P Ceranowicz; S J Konturek; J Stachura; E G Hahn Journal: J Physiol Pharmacol Date: 1997-03 Impact factor: 3.011
Authors: H Friess; R Duarte; J Kleeff; A Fukuda; W H Tang; H Graber; M Schilling; A Zimmermann; M Korc; M W Büchler Journal: Surgery Date: 1998-07 Impact factor: 3.982
Authors: Ahsan U Shah; Amna Sarwar; Abrahim I Orabi; Samir Gautam; Wayne M Grant; Alexander J Park; Adnan U Shah; Jun Liu; Pramod K Mistry; Dhanpat Jain; Sohail Z Husain Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-11 Impact factor: 4.052
Authors: John F Eisses; Angela Criscimanna; Zachary R Dionise; Abrahim I Orabi; Tanveer A Javed; Sheharyar Sarwar; Shunqian Jin; Lili Zhou; Sucha Singh; Minakshi Poddar; Amy W Davis; Akif Burak Tosun; John A Ozolek; Mark E Lowe; Satdarshan P Monga; Gustavo K Rohde; Farzad Esni; Sohail Z Husain Journal: Am J Pathol Date: 2015-10-23 Impact factor: 4.307
Authors: Kamaldeen A Muili; Dong Wang; Abrahim I Orabi; Sheharyar Sarwar; Yuhuan Luo; Tanveer A Javed; John F Eisses; Syeda M Mahmood; Shunqian Jin; Vijay P Singh; Meena Ananthanaravanan; George Perides; John A Williams; Jeffery D Molkentin; Sohail Z Husain Journal: J Biol Chem Date: 2012-11-12 Impact factor: 5.157
Authors: Thomas R Kolodecik; Anamika M Reed; Kimie Date; Christine A Shugrue; Vikhil Patel; Shang-Lin Chung; Gary V Desir; Fred S Gorelick Journal: J Biol Chem Date: 2017-10-17 Impact factor: 5.157
Authors: M Alexandre; A K Uduman; S Minervini; A Raoof; C A Shugrue; E O Akinbiyi; V Patel; M Shitia; T R Kolodecik; R Patton; F S Gorelick; E C Thrower Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-07-26 Impact factor: 4.052